date,title,source
Oct-17-18,"The Daily Biotech Pulse: Eiger's Lymphoedema Drug Study Fails, Roche's Sales Rise",Benzinga
Oct-17-18,"ArQule to Report Third Quarter 2018 Financial Results on October 31, 2018",Business Wire
Oct-19-18,"New Research Coverage Highlights TIER REIT, Meridian Bioscience, ArQule, Greenlight Capital Re, ADT, and Turquoise Hill Resources  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Oct-19-18,"ArQule Presents Orphan Disease Clinical Data at the American Society of Human Genetics (ASHG) 2018 Annual Meeting for Its pan-AKT Inhibitor, Miransertib (ARQ 092)",Business Wire
Oct-31-18,Edited Transcript of ARQL earnings conference call or presentation 31-Oct-18 1:00pm GMT,Thomson Reuters StreetEvents
Oct-31-18,"ArQule (ARQL) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Oct-31-18,ArQule: 3Q Earnings Snapshot,Associated Press
Oct-31-18,ArQule Reports Third Quarter 2018 Financial Results,Business Wire
Nov-01-18,ArQule (ARQL) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Nov-08-18,ArQule to Present Clinical and Preclinical Data for ARQ 751 at the 30th EORTC/AACR/NCI Symposium,Business Wire
Nov-09-18,Edited Transcript of ARQL earnings conference call or presentation 31-Oct-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-12-18,Edited Transcript of ARQL earnings conference call or presentation 31-Oct-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-14-18,"ArQule to Present at the 30th Annual Piper Jaffray Healthcare Conference on November 28, 2018",Business Wire
Nov-16-18,ArQule Presents Clinical and Preclinical Data for ARQ 751 at the 30th EORTC/AACR/NCI Symposium,Business Wire
Nov-16-18,Options Traders Expect Huge Moves in ArQule (ARQL) Stock,Zacks
Nov-16-18,"The Daily Biotech Pulse: Mallinckrodt FDA Verdict, European Cheer For Bristol-Myers Squibb, Morphosys Clinches Licensing Deal",Benzinga
Nov-19-18,"ArQule to Present Clinical Data for its BTK Inhibitor, ARQ 531, at the 2018 American Society of Hematology (ASH) Annual Meeting",Business Wire
Nov-21-18,Could ArQule Incs (NASDAQ:ARQL) Investor Composition Influence The Stock Price?,Simply Wall St.
